Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Heart Lung. 2009 Sep 30;39(1):12. doi: 10.1016/j.hrtlng.2009.04.001

Table 2.

Comparison of Disease Specific Quality of Life Scores at Baseline and Post Ablation (n =52)

DISEASE SPECIFIC MEASURES ** Baseline mean (sd) Post Ablation mean (sd) Change Scores 95% CI p Value
Average Frequency of SVT episodes (−) % % < .05
 Not at all 4 70
 < 2–4 times a year 38 6
 Twice a month 15 2
 2–5 times a week 23 4
 At least daily or more often 20 18
Average Duration of SVT episodes (−) % % ns
 Not Applicable 4 67
 A few seconds to 5 minutes 34 20
 5–15 minutes 14 8
 20–45 minutes 20 0
 Longer than 1 hour 25 4
Number of Symptoms Score (−) 8.4 (4) 4.5 (4) −3.9 (−2.3, −5.3) <.001
Symptom Bothersomeness Score (−) 2.1 (1) 1.4 (1) −.70 (−.31, −1.0) <.001
Impact of SVT on Routine Activities (−) 28 (23) 10 (21) −18 (−13, −26) <.001
Days Missed Work or School (−) 1 (2) 2 (6) +1 (2.8, .67) ns
Days Cut Down on Activity (−) 7 (10) 3 (7) −4 (−7, −1) < .05

GENERIC MEASURES*
Health Distress (+) 63 (24) 82 (22) +19 (26.6, 10.3) < .001
Physical function (+) 75 (25) 88 (22) +13 (22.1, 6.4) .001
Vitality (+) 43 (25) 59 (23) +16 (25.8, 9.2) <.001
Mental Health (5 item) (+) 69(18) 76 (15) +7 (12.4, 2.3) .004
Mental Health Index (17-item) (+) 70 (17) 79 (14) +9 (12.6, 4.6) <.001

SVT= supraventricular tachycardia;

*

= median values; N/A= response choice of “not applicable”.

**

Negative change score indicates improvement post ablation and positive change score indicates worsening on all scales.

*

Positive change score indicates improvement post ablation.